Press Releases
Rho Presenting on the Importance of Early Patient Involvement in Clinical Trial Design at OCT Texas
DURHAM - Sep 9, 2019 - MEDIA ADVISORY
Rho Presenting on the Importance of Early Patient Involvement in
Clinical Trial Design at OCT Texas
WHAT: Rho, a full-service contract research organization (CRO), is showcasing its nearly 35-year history of success in drug development strategies and services at the Outsourcing in Clinical Trials (OCT) Texas 2019 Conference, the newest addition to the Outsourcing in Clinical Trials series, taking place September 11-12 in Houston.
Rho research scientist Samantha Hoopes, PhD, RAC, will be presenting on the importance of early patient involvement in clinical trial design during the first day of the conference. Her presentation will focus on where in the process to get patient input; how patient input can benefit enrollment, compliance and outcomes; and the right tactics to elicit meaningful input.
Attendees are also invited to stop by Rhos booth (#4) to learn more about the services they provide to ensure an efficient and a successful drug development process. For nearly 35 years, Rho has been helping pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services. These services include clinical operations, project management, data management, data standards and biostatistics with extensive experience in many therapeutic areas.
WHO: Samantha Hoopes, PhD, RAC, research scientist, Rho
WHEN: Conference: Sept. 11-12, 2019
Hoopes Presentation: Sept. 11 at 11:45am
WHERE: Hilton Houston Plaza / Medical Center
6633 Travis St, Houston, Texas 77030
DETAILS: For media inquiries, please contact Kelly Maicon at Largemouth Communications, (919) 741-9784, kmaicon@largemouthpr.com.
ABOUT: Rho, a privately-held, contract research organization (CRO) located in Research Triangle Park, NC, provides a full range of clinical research services across the entire drug development process. For more than 35 years, Rho has been a trusted partner to some of the industrys leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. Please follow us on Facebook, LinkedIn and Twitter.
